ClearPoint Neuro amends CEO, CFO, COO employment agreements with enhanced severance and equity vesting

ClearPoint Neuro, Inc.

Amendments extend severance benefits to CEO Burnett, CFO D'Alessandro, and COO Sabra upon company non-renewal of term.
Pre-amendment outstanding time-based options and restricted stock fully vest on qualifying termination (without cause, good reason, or expiration).
Post-amendment awards: only shares scheduled to vest within 12 months of termination accelerate; exercise period reduced to 1 year.
All three executives receive unlimited paid time off under company's Section 16 officer policy.
Definitions of Termination Upon Expiration, Termination Without Cause, and Voluntary Termination revised for clarity.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.